Search Stock:
BALAXI PHARMACEUTICALS (BALAXI) Key Ratios
P/E
Company50.93
Sector-6.13
A Price-to-Earnings of 50.93 means investors pay 50.93 units per 1 unit of earnings. This is higher than the sector average of -6.13.
P/B
Company0.5
Sector3.89
A P/B ratio of 0.5 shows market value relative to book value. This is lower than the sector average of 3.89.
ROA
Company0.72%
Sector-8.42%
Return on Assets shows a 0.72% profit per unit of asset. This is lower than the sector average of -8.42%.
ROE
Company0.57%
Sector29.67%
Return on Equity creates 0.57% profit per unit of equity. This is lower than the sector average of 29.67%.
ROCE
Company3.0%
Sector13.24%
ROCE indicates 3.0% operating earnings per unit of capital. This is lower than the sector average of 13.24%.
EV/EBITDA
Company13.37
Sector-11.14
EV/EBITDA of 13.37 means value is 13.37 times core earnings. This is higher than the sector average of -11.14.
BALAXI PHARMACEUTICALS Share Price Analysis API (Live)
BALAXI PHARMACEUTICALS share price is ₹22.77, day high (share price) is ₹23.10, day low (share price) is ₹22.35 and volume is 22,106. 52 Week high share price for BALAXI PHARMACEUTICALS is ₹49.65 on 21 Aug 2025 and 52 week low share price for BALAXI PHARMACEUTICALS is ₹15.20 on 27 Mar 2026. Price data as of: 01 Sep, 2026 3:31 PM.
According to latest price data (as of 01 Sep, 2026 3:31 PM) for BALAXI PHARMACEUTICALS share, 14 day period RSI (Relative Strength Index) is 42.4, 50 DMA (50 Displaced Moving Average) is 23.70 and 200 DMA (200 Displaced Moving Average) is 25.21.
▲
₹22.77
0.43 (1.92%)
As of 01 Sep, 2026
Open
₹22.35
Day High - Low
₹23.10 - ₹22.35
Volume
22,106
52 Weeks High
₹49.65
on 21 Aug 2025
52 Weeks Low
₹15.20
on 27 Mar 2026
RSI (14)
42.4
50 DMA
23.70
200 DMA
25.21
Loading...
BALAXI PHARMACEUTICALS - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 65.99% | 65.99% | 65.99% | 65.99% |
| FII | 0.00% | 0.00% | 1.74% | 3.50% |
| DII (Other) | 2.56% | 2.56% | 0.02% | 0.02% |
| Retail & Others | 31.45% | 31.45% | 32.24% | 30.49% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
BALAXI PHARMACEUTICALS - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 272.99 -5.49% | 5.29 -81.55% | 1.42 -94.34% |
| Mar 2025 | 288.84 +21.04% | 28.67 -28.88% | 25.07 -30.19% |
| Mar 2024 | 238.64 -29.62% | 40.31 -29.18% | 35.91 -21.87% |
| Mar 2023 | 339.07 | 56.92 | 45.96 |
BALAXI PHARMACEUTICALS Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...
